Zobrazeno 1 - 10
of 191
pro vyhledávání: '"Barry Iacopetta"'
Autor:
Barry Iacopetta, Fabienne Grieu
Publikováno v:
BioTechniques, Vol 28, Iss 3, Pp 566-570 (2000)
Almost all tumors from patients with hereditary non-polyposis colon carcinoma and approximately 10%–15% of sporadic colon and gastric carcinomas contain widespread deletions within mono- and dinucleotide repeat sequences in their DNA. This is refer
Externí odkaz:
https://doaj.org/article/0203097414be4494a1c628eec5b823d7
Autor:
Wendy K Glenn, Benjamin Heng, Warick Delprado, Barry Iacopetta, Noel J Whitaker, James S Lawson
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48788 (2012)
The purpose of this investigation is to determine if Epstein Barr virus (EBV), high risk human papillomavirus (HPV), and mouse mammary tumour viruses (MMTV) co-exist in some breast cancers.All the specimens were from women residing in Australia. For
Externí odkaz:
https://doaj.org/article/ef8c649a04ec4f4f88e9a6dee7b5c0ec
Autor:
Dominic V. Spagnolo, Michael Millward, Benhur Amanuel, Fabienne Grieu-Iacopetta, Barry Iacopetta, Tindaro Giardina, Cleo Robinson
Publikováno v:
Pathology. 50:389-401
The introduction of next generation sequencing (NGS) in the routine diagnostic setting is still in the development phase and has been limited by its complexity. Targeted NGS offers an attractive alternative to performing multiple single target assays
Autor:
Hon Lyn Tan, Richie Soong, Barry Iacopetta, Rebecca Teng, Ross A. Soo, Bee Choo Tai, Zhaojin Chen
Publikováno v:
Oncotarget
// Ross A. Soo 1, 2, 5 , Zhaojin Chen 3 , Rebecca Siew Yan Teng 4 , Hon-Lyn Tan 1 , Barry Iacopetta 5 , Bee Choo Tai 3, 6 and Richie Soong 2, 7 1 Department of Haematology-Oncology, National University Health System, Singapore 2 Cancer Science Instit
Autor:
Maria Cynthia Herrera, Mohd Feroz Mohd Omar, Benhur Amanuel, Nguyen Hoang Diem Phuong, Zul Fazreen, Ju Ee Seet, Richie Soong, Joey Sze Yun Lim, David J Byrne, Shona Hendry, Barry Iacopetta, Ross A. Soo, Bernadette Reyna Asuncion, Stephen B. Fox
Publikováno v:
Oncotarget
Programmed death ligand-1 (PD-L1) expression as determined by immunohistochemistry (IHC) is potentially predictive of clinical outcome. The aim of this study was to assess the concordance of reported PD-L1 IHC assays and investigate factors influenci
Autor:
Bhaskar Bhattacharya, Mounia Beloueche-Babari, Richie Soong, Gim Hwa Tan, Mohd Feroz Mohd Omar, Min Ji Han, Ross A. Soo, King Xin Koh, Sarah Hong Hui Low, Barry Iacopetta
Publikováno v:
Oncotarget
Acquired resistance (AQR) to drug treatment occurs frequently in cancer patients and remains an impediment to successful therapy. The aim of this study was to gain insight into how AQR arises following the application of PI3K/mTOR inhibitors. H1975 l
Autor:
Cameron Platell, Christine Hemmings, Max Bulsara, Barry Iacopetta, Melanie J. McCoy, Tim J. Miller
Publikováno v:
Pathology. 49:24-29
Analysis of immunohistochemical expression is often a subjective and semiquantitative process that can lead to the inconsistent reporting of results. To assess the effect that region selection and quantification method have on results, five different
Publikováno v:
Oncology Letters
Immunoediting is defined as a process whereby tumour cells develop the capacity to escape immune cell recognition. Accumulating evidence suggests that cancer stem-like cells (CSCs) have an enhanced capacity to interact with the immune system. The exp
Autor:
Samantha Bowyer, Michael Millward, Fabienne Grieu-Iacopetta, Michelle Trevenen, Benhur Amanuel, Barry Iacopetta, Alison White, Connull Leslie
Publikováno v:
Pathology. 47:557-563
Tumour infiltrating lymphocytes in primary melanoma have been found to correlate with patient outcomes. A subpopulation of tumour infiltrating lymphocytes expresses the transcription factor forkhead box protein 3 (FOXP3). These are known as FOXP3+ T-
Autor:
Hui Ling Yap, Xiao Han, Yik Ying Teo, Eiram Elahi, Thomas P. Klemm, Touati Benoukraf, Barry Iacopetta, Richie Soong, Marie Loh, Hong Kiat Ng, Nur Sabrina Sapari, Mengchu Wu, Brendan Pang, Soo-Chin Lee
Publikováno v:
Clinical Chemistry. 60:1549-1557
BACKGROUND Next generation sequencing (NGS) promises many benefits for clinical diagnostics. However, current barriers to its adoption include suboptimal amenability for low clinical throughputs and uncertainty over data accuracy and analytical proce